Figure 2.
Identification of CD4 T cells, their subsets, and Tregs in patient groups. (A) Sequential gating strategy for identification of CD4 and its subsets using CCR7 and CD45RA, i.e., TCM, TNAIVE, TEM, and TEMRA. Scatter dot plot shows %frequency of CD4 T cells in patient groups. (B) Scatter dot plot shows %frequency of TCM, TNAIVE, TEM, and TEMRA. (C) Correlation between %CD4 TCM and total bilirubin in sepsis group. (D) UMAP visualization of pooled lymphocytes of HCs and patients w/o and with sepsis for characterization of Tregs. (E) Scatter dot plots show %frequency of Tregs. (F) ROC curve shows high specificity and sensitivity of Tregs in sepsis group compared to w/o sepsis group. Also, correlation of %Tregs with MELD in sepsis group. Results are expressed as the mean ± SD. (A, B, E) One-way ANOVA/Kruskal–Wallis test followed by probability adjustment by the Mann–Whitney. (C–F) Scatter diagram showing the regression line. UMAP, Uniform Manifold Approximation and Projection; HCs, healthy controls; ROC, receiver operating characteristic; MELD, model for end-stage liver diseases.